The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often in Biotech.
We are a venture capital firm investing in about-to-be clinical and clinical stage private companies in Europe and the USA.
Venture capitalStockholm, SE, Officesoundbioventures.comRounds from 2022-11-10 to 2026-09-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Breye Therapeutics A clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases | Series A Verified against 4 of 11 sources | $75.8M | 2026-09-29 | [ PART ] |
AnaCardio A clinical-stage biopharmaceutical company developing novel therapies for heart failure | Series B |
| $71.0M |
| 2026-09-29 |
| [ PART ] |
Breye Therapeutics A clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases | Seed Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $4.0M | 2022-11-10 | [ LEAD ] |